BEIJING, Dec. 28, 2023 /PRNewswire/ — In a short video, silver-haired “Grandma Wu” demonstrates various physics experiments using everyday items. She uses an iron pot to simulate the radio telescope, a broom to simulate cosmic rays in space, a badminton racket to simulate a positron-electron collider, and ginkgo leaves to make origami butterflies. Grandma Wu… Continue reading Global Times: Senior vloggers embrace vibrant twilight years in fashionable ways, showcase a more dignified old age with stronger security
Category: Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in the The Lovesac Company of Class Action Lawsuit and Upcoming Deadlines- LOVE
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against The Lovesac Company (“Lovesac” or the “Company”) (NASDAQ: LOVE). The class action, filed in the United States District Court for the District of Connecticut, and docketed under 23-cv-01640, is n on behalf of a class consisting of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in the The Lovesac Company of Class Action Lawsuit and Upcoming Deadlines- LOVE
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in General Motors Company of Class Action Lawsuit and Upcoming Deadline – GM
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against General Motors Company (“GM” or the “Company”) (NYSE: GM) and certain officers. The class action, filed in the United States District Court for the Eastern District of Michigan, Southern Division, and docketed under 23-cv-13132, is on behalf… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in General Motors Company of Class Action Lawsuit and Upcoming Deadline – GM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Roblox Corporation – RBLX
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Roblox and certain of its officers and/or directors have engaged in securities fraud or other unlawful business… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Roblox Corporation – RBLX
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in LivePerson, Inc. of Class Action Lawsuit and Upcoming Deadline – LPSN
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 23-cv- 10517, is on behalf of… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments in LivePerson, Inc. of Class Action Lawsuit and Upcoming Deadline – LPSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dollar General Corporation – DG
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dollar General Corporation (“Dollar General” or the “Company”) (NYSE: DG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Dollar General and certain of its officers and/or directors have engaged in… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dollar General Corporation – DG
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of EHang Holdings Ltd. – EH
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of EHang Holdings Ltd. (“EHang” or the “Company”) (NASDAQ: EH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether EHang and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of EHang Holdings Ltd. – EH
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of National Instruments Corporation – NATI
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of National Instruments Corporation (“NATI” or the “Company”) (NASDAQ: NATI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether NATI and certain of its officers and/or directors have engaged in securities… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of National Instruments Corporation – NATI
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Microvast Holdings, Inc. – MVST
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Microvast Holdings, Inc. (“Microvast” or the “Company”) (NASDAQ: MVST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Microvast and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Microvast Holdings, Inc. – MVST
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Eagle Pharmaceuticals, Inc. – EGRX
NEW YORK, Dec. 28, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (NASDAQ: EGRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Eagle and certain of its officers and/or directors have engaged in securities fraud or… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors in Eagle Pharmaceuticals, Inc. – EGRX